20 June 2013
Keywords: Pharma research productivity, Thomson Reuters, R&D spending, NMEs
Article | 29 June 2010
Leading R&D-based drugmakers continue to rely heavily on sales from an aging portfolio of drugs, while the proportion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 June 2010
30 June 2010
19 June 2013
© 2013 thepharmaletter.com